← Back to All Tools
🫀

MELD 3.0 & MELD-Na Liver Disease Mortality Calculator

Calculate Model for End-Stage Liver Disease (MELD 3.0 and MELD-Na) scores and 90-day pre-transplant mortality risk from bilirubin, creatinine, INR, sodium, and albumin.

Calculation Results

MELD 3.0 Score: 21 MELD-Na (OPTN 2016): 19
Estimated 90-Day Mortality Risk: 19.6%
Liver Transplant Priority Tier: Moderate-High Urgency
Clinical Recommendation: Active UNOS Liver Transplant Evaluation

About This Calculator

Calculate Model for End-Stage Liver Disease (MELD 3.0 and MELD-Na) scores and 90-day pre-transplant mortality risk from bilirubin, creatinine, INR, sodium, and albumin.

Frequently Asked Questions

What is MELD 3.0 and how does it differ from MELD-Na?

Implemented by the Organ Procurement and Transplantation Network (OPTN) in July 2023, MELD 3.0 adds serum albumin, includes interaction terms, and awards a +1.33 point adjustment for females to correct for historical underestimation of renal dysfunction in women caused by lower baseline serum creatinine.

What is the MELD score used for?

The MELD score determines waitlist priority for adult deceased donor liver allocation in the United States under UNOS/OPTN policies, ranking patients based on objective 90-day pre-transplant mortality risk.

Why is serum creatinine capped at 3.0 mg/dL?

In MELD 3.0, creatinine is bounded between 1.0 and 3.0 mg/dL (or set to 3.0 if the patient underwent dialysis twice in the preceding 7 days) to prevent extreme renal values from disproportionately skewing liver allocation.

What score indicates the need for liver transplant listing?

Generally, adult patients with end-stage cirrhosis are evaluated and listed for liver transplantation once their MELD score reaches 15 or higher, where post-transplant survival clearly exceeds waitlist survival.